Dr. Alan Naim, MD

NPI: 1588008890
Total Payments
$6,922
2024 Payments
$3,279
Companies
36
Transactions
129
Medicare Patients
791
Medicare Billing
$108,387

Payment Breakdown by Category

Food & Beverage$5,591 (80.8%)
Consulting$1,100 (15.9%)
Education$231.12 (3.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $5,591 125 80.8%
Consulting Fee $1,100 2 15.9%
Education $231.12 2 3.3%

Top Paying Companies

Company Total Records Latest Year
GlaxoSmithKline, LLC. $1,100 2 $0 (2024)
ABBVIE INC. $647.93 21 $0 (2024)
CONMED Corporation $455.61 2 $0 (2021)
Janssen Biotech, Inc. $431.91 7 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $348.43 9 $0 (2024)
Aries Pharmaceuticals, Inc. $329.38 3 $0 (2018)
Regeneron Healthcare Solutions, Inc. $311.11 8 $0 (2024)
PFIZER INC. $311.10 6 $0 (2024)
IRONWOOD PHARMACEUTICALS, INC $286.54 9 $0 (2024)
Boston Scientific Corporation $206.36 2 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $3,279 55 GlaxoSmithKline, LLC. ($1,100)
2023 $617.21 23 Regeneron Healthcare Solutions, Inc. ($200.74)
2022 $328.26 8 E.R. Squibb & Sons, L.L.C. ($140.61)
2021 $165.68 1 CONMED Corporation ($165.68)
2020 $102.11 4 Gilead Sciences, Inc. ($56.79)
2019 $655.40 5 CONMED Corporation ($289.93)
2018 $976.91 15 AbbVie, Inc. ($237.84)
2017 $797.30 18 Aries Pharmaceuticals, Inc. ($288.35)

All Payment Transactions

129 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
12/19/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $32.83 General
Category: Immunology
12/05/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $15.38 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
11/27/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $16.92 General
Category: Gastroenterology
11/21/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $28.08 General
Category: LIVER DISEASE
11/19/2024 QOL Medical, LLC SUCRAID (Drug) Food and Beverage Cash or cash equivalent $13.78 General
Category: THERAPY FOR CSID
11/13/2024 IRONWOOD PHARMACEUTICALS, INC Linzess (Drug) Food and Beverage Cash or cash equivalent $18.57 General
Category: GI
11/07/2024 Celltrion USA Inc. VEGZELMA (Biological) Food and Beverage In-kind items and services $3.69 General
Category: ONCOLOGY
11/04/2024 IRONWOOD PHARMACEUTICALS, INC Linzess (Drug) Food and Beverage Cash or cash equivalent $23.28 General
Category: GI
10/25/2024 AIMMUNE THERAPEUTICS, INC. VOWST (Biological) Food and Beverage In-kind items and services $33.57 General
Category: GI
10/24/2024 Janssen Biotech, Inc. TREMFYA (Drug), STELARA Food and Beverage In-kind items and services $142.13 General
Category: Immunology
10/22/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage In-kind items and services $119.35 General
Category: Immunology
10/12/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $24.08 General
Category: LIVER DISEASE
10/10/2024 Celltrion USA Inc. VEGZELMA (Biological) Food and Beverage In-kind items and services $9.91 General
Category: ONCOLOGY
10/01/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $22.31 General
Category: GASTROENTEROLOGY
10/01/2024 Janssen Biotech, Inc. TREMFYA (Drug), SIMPONI, SIMPONI ARIA Food and Beverage In-kind items and services $7.35 General
Category: Immunology
09/30/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $19.77 General
Category: LIVER DISEASE
09/26/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $24.11 General
Category: Gastroenterology
09/26/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $20.14 General
Category: Gastroenterology
09/25/2024 Janssen Biotech, Inc. TREMFYA (Drug), STELARA Food and Beverage In-kind items and services $118.80 General
Category: Immunology
09/16/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $25.61 General
Category: Immunology
09/03/2024 AIMMUNE THERAPEUTICS, INC. VOWST (Biological) Food and Beverage In-kind items and services $25.98 General
Category: GI
09/03/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $15.00 General
Category: GASTROENTEROLOGY
08/29/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $187.78 General
Category: GASTROENTEROLOGY
08/21/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $26.96 General
Category: GASTROENTEROLOGY
08/14/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $21.07 General
Category: Gastroenterology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 9 706 936 $386,340 $95,806
2022 4 85 124 $32,520 $12,581
Total Patients
791
Total Services
1,060
Medicare Billing
$108,387
Procedure Codes
13

All Medicare Procedures & Services

13 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 126 129 $67,725 $18,427 27.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 93 155 $31,000 $16,533 53.3%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 126 233 $44,270 $15,446 34.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 106 106 $34,450 $14,003 40.6%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 77 124 $33,480 $12,262 36.6%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 42 42 $72,240 $7,273 10.1%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 70 75 $63,750 $6,040 9.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 37 43 $7,525 $3,132 41.6%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 29 29 $31,900 $2,690 8.4%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 30 30 $9,750 $4,336 44.5%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 21 58 $11,020 $3,465 31.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 20 22 $4,400 $2,455 55.8%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 14 14 $7,350 $2,325 31.6%

About Dr. Alan Naim, MD

Dr. Alan Naim, MD is a Gastroenterology healthcare provider based in Phoenix, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/18/2013. The National Provider Identifier (NPI) number assigned to this provider is 1588008890.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Naim, MD has received a total of $6,922 in payments from pharmaceutical and medical device companies, with $3,279 received in 2024. These payments were reported across 129 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($5,591).

As a Medicare-enrolled provider, Naim has provided services to 791 Medicare beneficiaries, totaling 1,060 services with total Medicare billing of $108,387. Data is available for 2 years (2022–2023), covering 13 distinct procedure/service records.

Practice Information

  • Specialty Gastroenterology
  • Location Phoenix, AZ
  • Active Since 04/18/2013
  • Last Updated 07/21/2022
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • NPI Number 1588008890

Products in Payments

  • DUPIXENT (Biological) $457.75
  • TREMFYA (Drug) $431.91
  • ELEVIEW (Device) $329.38
  • CONMED BILIARY (Device) $289.93
  • Linzess (Drug) $286.54
  • ZEPOSIA (Drug) $255.12
  • XIFAXAN (Drug) $239.05
  • GENERAL BILIARY DEVICES (Device) $206.36
  • IBSRELA (Drug) $202.78
  • VOQUEZNA (Drug) $202.49
  • XELJANZ (Drug) $189.75
  • Humira (Biological) $189.70
  • CONMED HEMOSTASIS (Device) $165.68
  • ZYMFENTRA (Biological) $162.12
  • Epclusa (Drug) $125.00
  • Mavyret (Drug) $124.88
  • STELARA (Biological) $123.32
  • Austedo XR (Drug) $120.85
  • OMVOH (Drug) $119.35
  • Da Vinci Surgical System (Device) $114.90

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in Phoenix